Published in Bone Marrow Transplant on December 01, 1998
Loss of T cell responses following long-term cryopreservation. J Immunol Methods (2007) 1.23
Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo. Stem Cell Reports (2014) 1.03
Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease. PLoS One (2015) 0.76
Integrin involvement in freeze resistance of androgen-insensitive prostate cancer. Prostate Cancer Prostatic Dis (2010) 0.75
Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer (1988) 3.66
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia (2005) 3.43
Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 3.22
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood (2000) 2.70
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood (2000) 2.48
Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet (1991) 2.33
Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma (2004) 2.20
Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch Neurol (2000) 2.08
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol (1997) 1.90
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood (2000) 1.81
Decision aids: are they worth it? A systematic review. J Health Serv Res Policy (2001) 1.78
Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature. Int J Lab Hematol (2008) 1.77
Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood (2001) 1.76
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood (1988) 1.69
CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology (2002) 1.68
Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer (1993) 1.63
Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys (1997) 1.62
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol (2005) 1.58
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology (2005) 1.52
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol (2002) 1.46
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
[Diagnosis and prognosis of gonadal damage after chemotherapy and irradiation]. Dtsch Med Wochenschr (1992) 1.41
Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 1.41
Subtypes of T-cell chronic lymphatic leukemia. Cancer (1983) 1.39
Haemophagocytosis in bone marrow rhabdomyosarcoma. Br J Haematol (1999) 1.39
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia (1995) 1.35
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye (Lond) (2007) 1.35
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res (2000) 1.28
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. J Immunother (2000) 1.27
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood (1999) 1.25
Systemic anaphylaxis--separation of cardiac reactions from respiratory and peripheral vascular events. Res Exp Med (Berl) (1990) 1.25
Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia (2006) 1.24
Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells. Br J Haematol (2000) 1.23
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J (2012) 1.22
Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann Oncol (2006) 1.17
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res (2001) 1.16
A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). J Am Geriatr Soc (1991) 1.15
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. J Immunol Methods (2001) 1.15
Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest (1984) 1.15
Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol (2000) 1.14
Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia (2005) 1.12
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia (2004) 1.10
A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer. Ann Oncol (2006) 1.10
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol (2005) 1.10
Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus. Clin Rheumatol (1991) 1.10
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia (2007) 1.09
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. Clin Cancer Res (1998) 1.09
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia (2009) 1.07
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia (2002) 1.07
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. Ann Oncol (2008) 1.06
Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell (2004) 1.06
Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol (1999) 1.06
Use of capillary blood count parameters in adults. Vox Sang (2007) 1.05
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia (2006) 1.05
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors. Ann Oncol (2009) 1.04
Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia (1991) 1.03
In the queue for coronary artery bypass grafting: patients' perceptions of risk and 'maximal acceptable waiting time'. J Health Serv Res Policy (1999) 1.03
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol (2001) 1.02
Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4. Biochem J (1996) 1.02
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol (2005) 1.01
Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia (2005) 1.01
Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J (1995) 1.00
Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial. Br J Cancer (2009) 1.00
Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res (1995) 0.99
Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology (1995) 0.99
Cerebral aspergillosis: tissue penetration is the key. Med Mycol (2009) 0.99
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients. Ann Oncol (2011) 0.98
Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines. Cancer Res (1991) 0.98
Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion. Int J Hematol (2010) 0.98
Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol (2004) 0.97
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant (2007) 0.97
Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2. Br J Haematol (2001) 0.97
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial. Ann Oncol (2009) 0.97
A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res (1994) 0.96
Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia. Blood Cancer J (2011) 0.96
Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood (1984) 0.96
Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res (1996) 0.96
Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation. Leukemia (2007) 0.96
Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol (2011) 0.96
Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer (1991) 0.95
Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia (2007) 0.95
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice. Leukemia (2011) 0.94
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer. Br J Cancer (2013) 0.94
The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Blood (2000) 0.94
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis. Ann Oncol (2008) 0.94